- Government Accountability Project
The Government Accountability Project (GAP) is the United States' leading
whistleblowerprotection organization. Through litigating of whistleblower cases, publicizing concerns and developing legal reforms, GAP’s mission is to protect the public interest by promoting government and corporate accountability. Founded in 1977, GAP is a non-profit, non-partisan advocacy organization with offices in Washington, D.C.and Seattle, Washington.
GAP is a nonprofit public interest group that promotes government and corporate accountability by advancing occupational free speech, defending whistleblowers, and empowering citizen activists. They pursue this mission through their Nuclear Oversight, International Reform, Corporate Accountability, Food & Drug Safety, Environmental Oversight, and Federal Employee/National Security programs. GAP is the nation's leading whistleblower protection organization.
Prominent GAP Clients
Gary Aguirre is a former
Securities and Exchange Commissionlawyer who investigated a politically sensitive insider trading case involving Pequot Capital Management. At first, his supervisors had supported his inquiry. But when he sought to subpoena the CEO of Morgan Stanley, John Mack, who had briefly served as chairman of Pequot, Aguirre’s supervisors refused to allow him to issue the subpoena, claiming that it would be difficult because of Mack’s powerful “political connections.” Aguirre was then fired, only eleven days after he had received a two-step pay raise and his supervisor had praised his work on the Pequot investigation. [ [http://www.nytimes.com/2006/06/23/business/23fund.html?ex=1308715200&en=b00ffb007840a6b1&ei=5088&partner=rssnyt&emc=rss "S.E.C. Is Reported to Be Examining a Big Hedge Fund."] "New York Times." June 23, 2006.]
Dr. Blumsohn was a senior medical faculty member specializing in bone health at
Sheffield Universityin England. In 2002, he agreed to conduct research for Procter & Gamble(P&G) to determine how the osteoporosis drug Actonelprevents bone fractures. He collected data but was prevented from analyzing his findings by P&G. In 2004, P&G allowed Blumsohn to review what the company purported to be the actual data set. In reviewing the data, Blumsohn realized that numerous graphs (illustrating Actonel’s effectiveness in preventing bone fractures) omitted 40 percent of a data set, apparently manipulating results to suit P&G’s marketing objectives. P&G officials told Blumsohn that if these additional data were included in the results, the study would have favored a competitor’s drug – Merck’s Fosamax. He was then suspended by the university for speaking out about the issue to BBC. In 2006, he succeeded in pressuring P&G to release the full data set which, as he anticipated, failed to support P&G’s claim that Actonel is as effective as industry leaders in treating osteoporosis. [ [http://www.whistleblower.org/content/press_detail.cfm?press_id=370 "Disputes Over Industry-Funded Medical Research a Growing Problem."] "Associated Press." February 22, 2006.] See also [http://www.slate.com/id/2133061/ Slate report] , [http://www.aaas.org/spp/sfrl/per/per46.pdf AAAS reference] , and [http://scientific-misconduct.blogspot.com Blog] for further description of this incident.
Dr. David Graham, an FDA scientist, discovered that the pain-reliever Vioxx increased risk of cardiovascular problems. Despite threats from the FDA, Graham testified to the dangers of the drug and succeeded in convincing the FDA to require large warning labels on
Vioxxpackaging. [ [http://www.nytimes.com/2004/11/04/national/04drug.html?ex=1182916800&en=cf2a3b33da5d4a02&ei=5070 "Drug-Safety Reviewer Says FDA Delayed Vioxx Study."] "New York Times." November 4, 2004.]
Dr. Hampshire was an FDA scientist who uncovered the dangers of an FDA-approved heartworm medication that had killed hundreds of dogs. The drug’s producer,
Wyeth Pharmaceuticals, tried to counter Dr. Hampshire’s claim by attacking her character. The then-acting FDA Commissioner Lester Crawfordgranted Wyeth a private meeting in which the company presented him with “information” about Dr. Hampshire. Following this meeting, officials at the FDA’s Center for Veterinary Medicineremoved Dr. Hampshire from the study of Wyeth’s product without explanation. She was then subjected to an FDA criminal investigation. Dr. Hampshire sought help from GAP, and the Veterinary Medicine Advisory Committee then voted to take the heartworm drug off the market. She was completely exonerated in the FDA’s internal investigation, and received an award for her work. Senator Charles Grassleysoon launched an investigation into the actions of both Wyeth and the FDA. [ [http://www.nytimes.com/2005/12/06/politics/06fda.html?ex=1291525200&en=a7bd9288bf108703&ei=5088&partner=rssnyt&emc=rss "FDA Official Chides Agency Over Treatment.] "New York Times." December 6, 2005.]
Dr. Hansen is the top climate scientist at
NASA, who in late 2005 released data showing that 2005 was the warmest year in a century and gave a lecture calling on U.S. leadership to reduce emissions of greenhouse gaseslinked to global warming. He then received messages from NASA officials threatening “dire consequences” if such statements continued. Restrictions were placed on his ability to speak publicly about climate change research, including a requirement that public affairs staff review his lectures, papers, and web postings before releasing them. News media were repeatedly denied interviews with Hansen by his supervisors, and drafts of his reports are severely edited before publication. [ [http://www.nytimes.com/2006/01/29/science/earth/29climate.html?ex=1296190800&en=28e236da0977ee7f&ei=5088 "Climate Expert Says NASA Tried to Silence Him."] "New York Times." January 29, 2006.]
Rick Piltzworked for years as an associate with the U.S. Climate Change Science Program. In June 2005 news reports, documents that Piltz obtained showed that a White House official with no scientific training was editing climate change science program reports in an attempt to confuse and obscure the perceived human impact on global warming. That official, previously a lead lobbyist for the American Petroleum Institute, was hired by ExxonMobilmere days after leaving the White House (on the heels of the story). Piltz is currently the director of Climate Science Watch, a GAP program that holds public officials accountable for how they use climate science. [ [http://select.nytimes.com/gst/abstract.html?res=F10710F6385C0C7B8CDDAF0894DD404482&n=Top%2fNews%2fScience%2fTopics%2fGlobal%20Warming "Bush Aide Edited Climate Reports."] "New York Times." June 8, 2005.]
In late 2004, Andrew Thomson was fired from the
United Nationsfor publishing a book that was highly critical of the international body for mismanagement of its peacekeeping operations. In March 2005, his termination was reversed and he was promoted after Secretary General Kofi Annan, in an unprecedented decision, permitted public whistleblowing by U.N. employees. In January of the following year, the United Nations issued a new standard of whistleblower protection in an anti-retaliation policy, on which GAP was consulted. [ [http://www.nytimes.com/2005/01/06/international/africa/06book.html?ex=1182916800&en=90e08a8c571ad859&ei=5070 "UN Eases Stand on Doctor Who Criticized Peacekeeping Role."] "New York Times." January 6, 2005.]
GAP and Paul Wolfowitz
In early 2007, GAP was responsible for exposing fraud and abuse at the highest levels of the
World Bank. [ [http://www.washingtonpost.com/wp-dyn/content/article/2007/03/27/AR2007032701953.html "Where the Money Is."] "Washington Post." March 28, 2007.] In May 2007, World Bank President Paul Wolfowitzleft the international organization in the wake of wide-ranging scandals based on multiple releases of documents over the previous two months by GAP. [ [http://www.ft.com/cms/s/023bffd4-03cb-11dc-a931-000b5df10621,_i_rssPage=6700d4e4-6714-11da-a650-0000779e2340.html "Wolfowitz Steps Down as World Bank President."] "Financial Times." May 17, 2007.]
GAP released evidence or exposed information showing that: Wolfowitz’s companion,
Shaha Riza, received salary raises far in excess of those allowable under Bank rules; Riza received a questionable consulting position with a U.S. defense contractor in 2003 at Wolfowitz' direction that has resulted in State and Defense Department inquiries; Juan José Daboub, Bank Managing Director and Wolfowitz-hire, attempted to remove references and funding for “ family planning” in Bank projects; Wolfowitz’ office was responsible for weakening a “climate change” strategy document; Bank Senior Management delayed reporting to Bank staff that a fellow staffer had been seriously wounded in a shooting in Iraq; World Bank lending to Africa during Fiscal Year of 2007 has plummeted; and Wolfowitz was trying to broaden the Bank’s portfolio in Iraq over Board opposition.
* [http://www.whistleblower.org/ Government Accountability Project]
* [http://whistleblower.typepad.com/ GAP blog]
Wikimedia Foundation. 2010.